Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?
Journal of Thrombosis and Haemostasis · 2024
DOI: 10.1016/j.jtha.2024.02.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Toshiaki Iba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Electronic address: toshiiba@juntendo.a…. Hauptthemen laut MEDLINE: COVID-19, Blood Coagulation Disorders, SARS-CoV-2. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
Coagulopathy alongside micro- and macrovascular thrombotic events were frequent characteristics of patients presenting with acute COVID-19 during the initial stages of the pandemic. However, over the past 4 years, the incidence and manifestations of COVID-19-associated coagulopathy have changed due to immunity from natural infection and vaccination and the appearance of new SARS-CoV-2 variants. Diagnostic criteria and management strategies based on early experience and studies for COVID-19-associated coagulopathy thus require reevaluation. As many other infectious disease states are also associated with hemostatic dysfunction, the coagulopathy associated with COVID-19 may be compounded, especially throughout the winter months, in patients with diverse etiologies of COVID-19 and other infections. This commentary examines what we have learned about COVID-19-associated coagulopathy throughout the pandemic and how we might best prepare to mitigate the hemostatic consequences of emerging infection agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Electronic address: toshiiba@juntendo.ac.jp.
- Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Hematology Division Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands; Department of Medicine, University College London Hospitals NHS Foundation Trust, Cardio-metabolic Programme-National Ins…
Zitieren
APA
Iba, T., Levy, J. H., Maier, C. L., Connors, J. M., & Levi, M. (2024). Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.02.013
Vancouver
Iba T, Levy JH, Maier CL, Connors JM, Levi M. Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.02.013
BibTeX
@article{Iba2024,
author = {Iba, Toshiaki and Levy, Jerrold H and Maier, Cheryl L and Connors, Jean M and Levi, Marcel},
title = {Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
doi = {10.1016/j.jtha.2024.02.013}
}
EUVIMED